This inventor holds 8 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 5 EPO patents. Top assignees: Lg Chem, Ltd, Lg Life Sciences, Limited. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2025
Title: Seung Yup Paek: Innovator in Pharmaceutical Chemistry
Introduction
Seung Yup Paek is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors related to metabolic diseases.
Latest Patents
Paek holds 8 patents, with his latest innovations focusing on biaryl derivatives as GPR120 agonists. These compounds are designed for the prevention and treatment of inflammation and metabolic diseases such as diabetes, obesity, and osteoporosis. Another notable patent involves GPR40 receptor agonists, which promote insulin secretion and help manage blood sugar levels, making them valuable for diabetes treatment.
Career Highlights
Throughout his career, Seung Yup Paek has worked with reputable companies, including LG Life Sciences and LG Chem. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Paek has collaborated with notable colleagues, including Sung Bae Lee and Soon Ha Kim, contributing to various innovative projects in the pharmaceutical sector.
Conclusion
Seung Yup Paek's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the fight against metabolic diseases. His work continues to influence the development of effective treatments for these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile